AAAAAA
Results: 1-25/26
Authors:
Levy, V
Porcher, R
Leblond, V
Fermand, JP
Cazin, B
Maloisel, F
Harousseau, JL
Remenieras, L
Guibon, O
Chevret, S
Citation: V. Levy et al., Evaluating treatment strategies in advanced Waldenstrom macroglobulinemia:use of quality-adjusted survival analysis, LEUKEMIA, 15(9), 2001, pp. 1466-1470
Authors:
Soussain, C
Suzan, F
Hoang-Xuan, K
Cassoux, N
Levy, V
Azar, N
Belanger, C
Achour, E
Ribrag, V
Gerber, S
Delattre, JY
Leblond, V
Citation: C. Soussain et al., Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma, J CL ONCOL, 19(3), 2001, pp. 742-749
Authors:
Leblond, V
Dhedin, N
Bruneel, MFM
Choquet, S
Hermine, O
Porcher, R
Quoc, SN
Davi, F
Charlotte, F
Dorent, R
Barrou, B
Vernant, JP
Raphael, M
Levy, V
Citation: V. Leblond et al., Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders, J CL ONCOL, 19(3), 2001, pp. 772-778
Authors:
Hausfater, P
Cacoub, P
Sterkers, Y
Thibault, V
Amoura, Z
Nguyen, L
Ghillani, P
Leblond, V
Piette, JC
Citation: P. Hausfater et al., Hepatitis C virus infection and lymphoproliferative diseases: Prospective study on 1,576 patients in France, AM J HEMAT, 67(3), 2001, pp. 168-171
Authors:
Froussart, F
Clay, C
Leblond, V
Chaouat, D
D'Hermies, F
Renard, G
Citation: F. Froussart et al., Corneal crystalline deposits in monoclonal gammapathy: a report of two cases, J FR OPHTAL, 24(7), 2001, pp. 738-743
Authors:
Heuze-Vourc'h, N
Leblond, V
Olayat, S
Gauthier, F
Courty, Y
Citation: N. Heuze-vourc'H et al., Characterization of PSA-RP2, a protein related to prostate-specific antigen and encoded by alternative hKLK3 transcripts, EUR J BIOCH, 268(16), 2001, pp. 4408-4413
Authors:
Leblond, V
Levy, V
Maloisel, F
Cazin, B
Fermand, JP
Harousseau, JL
Remenieras, L
Porcher, R
Gardembas, M
Marit, G
Deconinck, E
Desablens, B
Guilhot, F
Philippe, G
Stamatoullas, A
Guibon, O
Citation: V. Leblond et al., Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstrom macroglobulinemia in first relapse or with primary refractory disease, BLOOD, 98(9), 2001, pp. 2640-2644
Authors:
Haddad, E
Paczesny, S
Leblond, V
Seigneurin, JM
Stern, M
Achkar, A
Bauwens, M
Delwail, V
Debray, D
Duvoux, C
Hubert, P
de Ligny, BH
Wijdenes, J
Durandy, A
Fischer, A
Citation: E. Haddad et al., Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial, BLOOD, 97(6), 2001, pp. 1590-1597
Authors:
Boissel, N
Wechsler, B
Leblond, V
Citation: N. Boissel et al., Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation, ANN INT MED, 135(9), 2001, pp. 844-845
Authors:
Fiere, D
Vernant, JP
Michallet, M
Degos, L
Leblond, V
Olteanu, N
Boucheix, C
Charrin, C
Varet, B
Huguet, FR
Delannoy, A
Gratecos, N
Lepage, E
Sebban, C
Citation: D. Fiere et al., Treatment of adult acute lymphoblastic leukemia long term results of a prospective study: LALA 87, HEMAT BLOOD, 40, 2001, pp. 389-392
Authors:
Peyromaure, M
Van Glabeke, E
Leblond, V
Barrou, B
Delcourt, A
Richard, F
Citation: M. Peyromaure et al., Primary lymphoma of the bladder., PROG UROL, 10(6), 2000, pp. 1208-1211
Authors:
Cassoux, N
Merle-Beral, H
Leblond, V
Bodaghi, B
Milea, D
Gerber, S
Fardeau, C
Reux, I
Xuan, KH
Chan, CC
LeHoang, P
Citation: N. Cassoux et al., Ocular and central nervous system lymphoma: clinical features and diagnosis, OCUL IMMU I, 8(4), 2000, pp. 243-250
Authors:
Milpied, N
Vasseur, B
Parquet, N
Garnier, JL
Antoine, C
Quartier, P
Carret, AS
Bouscary, D
Faye, A
Bourbigot, B
Reguerre, Y
Stoppa, AM
Bourquard, P
de Ligny, BH
Dubief, F
Mathieu-Boue, A
Leblond, V
Citation: N. Milpied et al., Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients, ANN ONCOL, 11, 2000, pp. 113-116
Authors:
Leblond, V
Legendre, C
Gras, G
Dereuddre-Bosquet, N
Lafuma, C
Dormont, D
Citation: V. Leblond et al., Quantitative study of beta(1)-integrin expression and fibronectin interaction profile of T lymphocytes in vitro infected with HIV, AIDS RES H, 16(5), 2000, pp. 423-433
Authors:
Zompi, S
Tulliez, M
Conti, F
Leblond, V
Gaulard, P
Blanche, P
Durand, F
Ghandi, D
Dreyfus, F
Louvel, A
Calmus, Y
Bouscary, D
Citation: S. Zompi et al., Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases, J HEPATOL, 32(3), 2000, pp. 521-527
Authors:
Thomas, X
Cambier, N
Taksin, AL
Reman, O
Vekhoff, A
Pautas, C
Leblond, V
Soler-Michel, P
Ecstein-Fraisse, E
Archimbaud, E
Citation: X. Thomas et al., Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia, LEUK RES, 24(11), 2000, pp. 957-963
Authors:
Gabarre, J
Azar, N
Autran, B
Katlama, C
Leblond, V
Citation: J. Gabarre et al., High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma, LANCET, 355(9209), 2000, pp. 1071-1072
Authors:
Aslangul-Castier, E
Papo, T
Amoura, Z
Baud, O
Leblond, V
Charlotte, F
Bricaire, F
Degos, L
Piette, JC
Citation: E. Aslangul-castier et al., Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia, ANN RHEUM D, 59(5), 2000, pp. 390-393
Authors:
Martin, A
Baran-Marzak, F
El Mansouri, S
Legendre, C
Leblond, V
Charlotte, F
Davi, F
Canioni, D
Raphael, M
Citation: A. Martin et al., Expression of p16/INK4a in posttransplantation lymphoproliferative disorders, AM J PATH, 156(5), 2000, pp. 1573-1579
Authors:
Gonzalez, H
Bolgert, F
Camporo, P
Leblond, V
Citation: H. Gonzalez et al., Progressive multifocal leukoencephalitis (PML) in three patients treated with standard-dose fludarabine (FAMP), HEM CELL TH, 41(4), 1999, pp. 183-186
Authors:
Soussain, C
Souleau, B
Gabarre, J
Zouabi, H
Sutton, L
Boccaccio, C
Albin, N
Charlotte, F
Merle-Beral, H
Delort, J
Binet, JL
Leblond, V
Citation: C. Soussain et al., Intensive chemotherapy with hematopoietic cell transplantation after ESHAPtherapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patients, LEUK LYMPH, 33(5-6), 1999, pp. 543-550
Unsuccessful association of zidovudine and interferon alpha for acute adult T-cell leukemia lymphoma
Authors:
Dega, H
Chosidow, O
Charlotte, F
Frances, C
Herson, S
Leblond, V
Citation: H. Dega et al., Unsuccessful association of zidovudine and interferon alpha for acute adult T-cell leukemia lymphoma, DERMATOLOGY, 198(1), 1999, pp. 103-105
Authors:
Brice, P
Divine, M
Simon, D
Coiffier, B
Leblond, V
Simon, M
Voilat, L
Devidas, A
Morschhauser, F
Rohrlich, P
Andre, M
Lepage, E
Ferme, C
Citation: P. Brice et al., Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD), ANN ONCOL, 10(12), 1999, pp. 1485-1488
Authors:
Thomas, X
Fenaux, P
Dombret, H
Delair, S
Dreyfus, F
Tilly, H
Vekhoff, A
Cony-Makhoul, P
Leblond, V
Troussard, X
Cordonnier, C
de Revel, T
Simon, M
Nicolini, F
Stoppa, AM
Janvier, M
Bordessoule, D
Rousselot, P
Ffrench, M
Marie, JP
Archimbaud, E
Citation: X. Thomas et al., Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial), LEUKEMIA, 13(8), 1999, pp. 1214-1220
Authors:
Mollet, L
Fautrel, B
Leblond, V
Bergeron, F
Merle-Beral, H
Baumelou, E
Hubert, P
Debre, P
Autran, B
Citation: L. Mollet et al., Leukemic CD3(+) LGL share functional properties with their CD8(+)CD57(+) cell counterpart expanded after BMT, LEUKEMIA, 13(2), 1999, pp. 230-240